检索结果 - Czuczman, Myron

Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma 由 Barth, Matthew J., Mavis, Cory, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

获取全文 获取全文 获取全文

Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin lymphoma (B-NHL) 由 Tsai, Ping-Chiao, Hernandez-Ilizaliturri, Francisco J., Bangia, Naveen, Olejniczak, Scott, Czuczman, Myron S.

获取全文 获取全文 获取全文

Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cells 由 Gu, Juan J., Kaufman, Gregory P., Mavis, Cory, Czuczman, Myron S, Hernand ez-Ilizaliturri, Francisco J.

获取全文 获取全文 获取全文

The novel proteasome inhibitor carfilzomib (CFZ) induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma 由 Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Kaufman, Gregory P., Czuczman, Natalie M., Mavis, Cory, Skitzki, Joseph J., Czuczman, Myron S.

获取全文 获取全文 获取全文

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody 由 Goldenberg, David M., Rossi, Edmund A., Stein, Rhona, Cardillo, Thomas M., Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J., Hansen, Hans J., Chang, Chien-Hsing

获取全文 获取全文 获取全文

MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-se... 由 Gu, Juan J., Hernandez-Ilizaliturri, Francisco J., Mavis, Cory, Czuczman, Natalie M., Deeb, George, Gibbs, John, Skitzki, Joseph J., Patil, Ritesh, Czuczman, Myron S.

获取全文 获取全文 获取全文

Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents 由 Frys, Sarah, Simons, Zachary, Hu, Qiang, Barth, Matthew J., Gu, Juan J., Mavis, Cory, Skitzki, Joseph, Song, Liu, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

获取全文 获取全文 获取全文

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma 由 Dunleavy, Kieron, Pittaluga, Stefania, Czuczman, Myron S., Dave, Sandeep S., Wright, George, Grant, Nicole, Shovlin, Margaret, Jaffe, Elaine S., Janik, John E., Staudt, Louis M., Wilson, Wyndham H.

获取全文 获取全文 获取全文

Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cells 由 Olejniczak, Scott H., Blickwedehl, Jennifer, Belicha-Villanueva, Alan, Bangia, Naveen, Riaz, Wasif, Mavis, Cory, Clements, James L., Gibbs, John, Hernandez-Ilizaliturri, Francisco J., Czuczman, Myron S.

获取全文 获取全文 获取全文

Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development 由 Gu, Juan J., Singh, Anil, Xue, Kai, Mavis, Cory, Barth, Matthew, Yanamadala, Vivek, Lenz, Peter, Grau, Michael, Lenz, Georg, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

获取全文 获取全文 获取全文

Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network 由 LaCasce, Ann S., Kho, Michelle E., Friedberg, Jonathan W., Niland, Joyce C., Abel, Gregory A., Rodriguez, Maria Alma, Czuczman, Myron S., Millenson, Michael M., Zelenetz, Andrew D., Weeks, Jane C.

获取全文 获取全文 获取全文

CALGB 150905 (Alliance): Rituximab broadens the anti-lymphoma response by activating unlicensed NK cells 由 Du, Juan, Lopez-Verges, Sandra, Pitcher, Brandelyn N., Johnson, Jeffrey, Jung, Sin-Ho, Zhou, Lili, Hsu, Katharine, Czuczman, Myron S., Cheson, Bruce, Kaplan, Lawrence, Lanier, Lewis L., Venstrom, Jeffrey M.

获取全文 获取全文 获取全文

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo 由 Czuczman, Natalie M., Barth, Matthew J., Gu, Juan, Neppalli, Vishala, Mavis, Cory, Frys, Sarah E., Hu, Qiang, Liu, Song, Klener, Pavel, Vockova, Petra, Czuczman, Myron S., Hernandez-Ilizaliturri, Francisco J.

获取全文 获取全文 获取全文

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study 由 Kahl, Brad S., Bartlett, Nancy L., Leonard, John P., Chen, Ling, Ganjoo, Kristen, Williams, Michael E., Czuczman, Myron S., Robinson, K. Sue, Joyce, Robin, van der Jagt, Richard H., Cheson, Bruce D.

获取全文 获取全文 获取全文

Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial 由 Xue, Kai, Gu, Juan J., Zhang, Qunling, Liu, Xiaojian, Wang, Jiachen, Li, Xiao-qiu, Luo, Jianfeng, Hernandez, Francisco J., Fernandez, Stanley F., Czuczman, Myron S., Cao, Junning, Hong, Xiaonan, Guo, Ye

获取全文 获取全文 获取全文

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials 由 Lansigan, Frederick, Barak, Ian, Pitcher, Brandelyn, Jung, Sin‐Ho, Cheson, Bruce D., Czuczman, Myron, Martin, Peter, Hsi, Eric, Schöder, Heiko, Smith, Scott, Bartlett, Nancy L., Leonard, John P., Blum, Kristie A.

获取全文 获取全文 获取全文

Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and... 由 Chanan-Khan, Asher A., Chitta, Kasyapa, Ersing, Noreen, Paulus, Aneel, Masood, Aisha, Sher, Taimur, Swaika, Abhisek, Wallace, Paul K., Mashtare, Terry L., Wilding, Greg, Lee, Kelvin, Czuczman, Myron S., Borrello, Ivan, Bangia, Naveen

获取全文 获取全文 获取全文

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies 由 Ogasawara, Ken, Newhall, Kathryn, Maxwell, Stephen E., Dell’Aringa, Justine, Komashko, Vitalina, Kilavuz, Nurgul, Delarue, Richard, Czuczman, Myron, Sternas, Lars, Rose, Shelonitda, Beach, C. L., Novick, Steven, Zhou, Simon, Palmisano, Maria, Li, Yan

获取全文 获取全文 获取全文

A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype 由 Wilson, Wyndham H., Jung, Sin-Ho, Porcu, Pierluigi, Hurd, David, Johnson, Jeffrey, Martin, S. Eric, Czuczman, Myron, Lai, Raymond, Said, Jonathan, Chadburn, Amy, Jones, Dan, Dunleavy, Kieron, Canellos, George, Zelenetz, Andrew D., Cheson, Bruce D., Hsi, Eric D.

获取全文 获取全文 获取全文

Radiation for Diffuse Large B Cell Lymphoma in the Rituximab Era: Analysis of the National Comprehensive Cancer Network Lymphoma Outcomes Project 由 Dabaja, Bouthaina, Vanderplas, Ann M., Crosby-Thompson, Allison L., Abel, Gregory A., Czuczman, Myron S., Friedberg, Jonathan W., Gordon, Leo. I, Kaminski, Mark, Niland, Joyce, Millenson, Michael, Nademanee, Auayporn P., Zelenetz, Andrew, LaCasce, Ann S., Rodriguez, Maria Alma

获取全文 获取全文 获取全文